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Summary
 
Interleukin (IL)-18 induces interferon (IFN)-
 
g
 
 synthesis and synergizes with IL-12 in T helper
type 1 (Th1) but not Th2 cell development. We report here that IL-18 receptor (IL-18R) is
selectively expressed on murine Th1 but not Th2 cells. IL-18R mRNA was expressed consti-
tutively and consistently in long-term cultured clones, as well as on newly polarized Th1 but
not Th2 cells. IL-18 sustained the expression of IL-12R
 
b
 
2 mRNA, indicating that IL-18R
transmits signals that maintain Th1 development through the IL-12R complex. In turn, IL-12
upregulated IL-18R mRNA. Antibody against an IL-18R–derived peptide bound Th1 but not
Th2 clones. It also labeled polarized Th1 but not Th2 cells derived from naive ovalbumin–T
cell antigen receptor-
 
ab
 
 transgenic mice (D011.10). Anti–IL-18R antibody inhibited IL-18–
induced IFN-
 
g 
 
production by Th1 clones in vitro. In vivo, anti–IL-18R antibody reduced lo-
cal inflammation and lipopolysaccharide-induced mortality in mice. This was accompanied by
shifting the balance from Th1 to Th2 responses, manifest as decreased IFN-
 
g
 
 and proinflam-
matory cytokine production and increased IL-4 and IL-5 synthesis. Therefore, these data pro-
vide a direct mechanism for the selective effect of IL-18 on Th1 but not Th2 cells. They also
show that the synergistic effect of IL-12 and IL-18 on Th1 development may be due to the re-
ciprocal upregulation of their receptors. Furthermore, IL-18R is a cell surface marker distin-
guishing Th1 from Th2 cells and may be a therapeutic target.
Key words: T helper type 1 cells • T helper type 2 cells • interleukin 18 receptor • 
inﬂammation • septic shock
 
F
 
unctional heterogeneity of CD4
 
1
 
 T cells was recognized
in the 1970’s (1). Subsequently, Th1- and Th2-type T
cell responses have been classified by virtue of IFN-
 
g
 
/IL-2
and IL-4/IL-5 production, respectively (2). It is now gen-
erally accepted that the balance between these two T cell
subsets determines the phenotype and progression of nu-
merous experimental and clinical diseases (3–5). Therefore,
elucidating their preferential induction and regulation is of
considerable importance both in facilitating potential clini-
cal immunoregulatory applications and understanding fun-
damental immunology. Thus, there has been an intensive
search for genes and/or cell surface molecules selectively
expressed on Th1 or Th2 cells which are implicated in selec-
tively directing and regulating their biological functions.
Using differential display PCR, we have recently identi-
fied a gene encoding a cell surface molecule, originally des-
ignated ST2L/T1/DER4/Fit, expressed constitutively and
stably on murine Th2 but not Th1 cells, even after stimula-
tion with a range of immunological stimuli (6). Anti-ST2L
antibody can decrease Th2 functions in vitro and in vivo.
ST2L is a member of the IL-1R family with 28% amino acid
sequence homology with the type I IL-1R (7). Although
IL-1
 
a 
 
acts as a cofactor in IL-12–induced Th1 development
in BALB/c mice, IL-1
 
a 
 
responsiveness is lost by committed
Th1 cells and clones (8). Thus, members of the IL-1R fam-
ily may be differentially expressed and thereby regulate the
sequential functions of Th1 and Th2 cells. Therefore, we in-
vestigated other members of the IL-1R family for their ex-
pression and function in Th1 and Th2 cells. We have found
that a gene known as IL-1R–related protein (IL-1Rrp)
 
1
 
 (9)
 
1
 
Abbreviations used in this paper:
 
 DLN, draining lymph node(s); HPRT,
hypoxanthine phosphoribosyltransferase; IL-1Rrp, IL-1 receptor–related
protein; RT, reverse transcription.
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with previously unknown function was selectively ex-
pressed in Th1 but not Th2 cells. During the course of this
work, it was reported that human IL-18R shared complete
amino acid sequence homology with IL-1Rrp and has 30%
homology with ST2L (10). IL-18 is a cytokine produced
by monocytic cells capable of promoting proliferation and
IFN-
 
g
 
 production by Th1, CD8
 
1
 
, and NK cells in mice
and in humans (11). It shares some of the biological activi-
ties of IL-12 but without significant structural homology,
and serves as a costimulatory factor in the activation of Th1
but not Th2 cells (12). It appears not to drive Th1 develop-
ment but synergizes with IL-12 for IFN-
 
g
 
 production (8).
Consistent with this is the recent report that mice deficient
in IL-18 gene are defective in Th1 and NK cell activities (13).
In this study, we show that IL-18R is preferentially ex-
pressed on the surface of Th1 compared with Th2 cells. IL-18
and IL-12 reciprocally upregulated each other’s receptors.
Furthermore, anti–IL-18R antibody decreased the func-
tions of Th1 cells in vitro and in vivo. Therefore, these
findings provide a mechanism for the synergistic effect of
IL-12 and IL-18 in the development of Th1 but not Th2
cells. They also demonstrate that IL-18R is not only a se-
lective cell surface marker for Th1 cells, distinguishing
them from Th2 cells, but may also be an immunotherapeu-
tic target.
 
Materials and Methods
 
Mice.
 
BALB/c and CBA mice were obtained from Harlan
UK Ltd. (Bicester, Oxon, UK). OVA-TCR-
 
ab 
 
transgenic mice
(D011.10) of the BALB/c background
 
 
 
were provided by Dr. Ken
Murphy (Washington University, St. Louis, MO).
 
Cell Lines and Cell Culture.
 
Murine T cell clones were as de-
scribed previously (6). Dorris (Th1, specific
 
 
 
for hen egg lyso-
zyme, H-2
 
k
 
) and D10 (Th2, specific for conalbumin, H-2
 
k
 
) were
obtained from American Type Culture Collection (Rockville, MD).
X4 (Th1) and X12 (Th2) were both H-2
 
d
 
–restricted and specific
against group A streptococcal M protein (14). The cells were
maintained by periodic antigen stimulation with appropriate irra-
diated spleen cells followed by expansion in medium containing
IL-2 for up to 4 wk. For short-term polarized T cell lines, CD4
 
1
 
cells were purified from the spleen of OVA-TCR-
 
ab 
 
transgenic
mice (D011.10; reference 15) by negative selection as described
previously (16). They were cultured with OVA peptide (0.3 
 
m
 
M,
OVA
 
323–339
 
) and irradiated BALB/c spleen cells in the presence of
IL-12 (40 U/ml) plus anti–IL-4 antibody (10 
 
m
 
g/ml, 11B11) for
Th1 line, or IL-4 (250 U/ml) plus anti–IL-12 (1/400, rabbit anti–
IL-12 antiserum, R73.1) and anti–IFN-
 
g
 
 (5 
 
m
 
g/ml, R46A2) an-
tibodies for Th2 line, for 7 d (16). IL-2 (10 U/ml) was added to
the culture from day 3. Clones and T cell lines were also cultured
in medium alone, in the presence of recombinant IL-2 (10 ng/
ml), IL-12 (10 ng/ml; both obtained from Genzyme Diagnostics,
Kent, UK), IL-18 (30 ng/ml; PeproTech EC Ltd., London, UK),
or a combination of IL-12 and IL-18.
 
Reverse Transcriptase PCR Southern Blot.
 
Primers for amplifying
IL-18R were as follows. IL-18R: sense, TTAGGACCAAAGTG-
TGAGAAGG, and antisense, TCTCGTCTCTTTCCGCTAT-
GCG (product of 459 bp); IL-12R
 
b
 
2: sense, AAAGCCAACT-
GGAAAGCATTCG, and antisense, AGTTTTGAGTCAGG-
GTCTCTGC (product of 466 bp); ST2L: sense, ACTTTGT-
TCACCACACTCTGC, and antisense, AACAGATGCCGTC-
TTGGAGGC (product of 450 bp); and hypoxanthine phosphori-
bosyltransferase (HPRT): sense, GTTGGATACAGGCCAGACT-
TTGTTG, and antisense, GAGGGTAGGCTGGCCTATAG-
GCT (product of 352 bp). PCR products were separated in 1%
agarose gels and transferred to nylon membranes which were hy-
bridized with cDNA probes labeled with [
 
a
 
-
 
32
 
P]dATP using the
random primer method (Promega, Southampton, UK). The cDNA
probes were generated by reverse transcription (RT)-PCR using
the primers mentioned above. The PCR fragments were cloned
into PCR-A/T vector (Invitrogen Corp., Carlsbad, CA), and se-
quences were confirmed by standard methods.
 
Northern Blot Analysis.
 
Total RNA was isolated from cells by
RNA-ZolB and was separated (20 
 
m
 
g/lane) in 1% formaldehyde/
agarose gels, blotted to nylon membrane, and hybridized with the
probes used for Southern blot above. The relative amount of the
messages was compared with HPRT using an imager analyzer
(Media Cybernetics, Inc., Silver Spring, MD). The membranes
were stripped according to the manufacturer’s recommendation
and reprobed as indicated.
 
Anti–IL-18R Antibody.
 
A rabbit was immunized with the
peptide corresponding to residues 247–266 of the murine IL-18R
amino acid sequence (IL-1Rrp in reference 9). The peptide span-
ning the hydrophilic region within the extracellular domain of
the molecule was selected for its uniqueness. The rabbit was im-
munized subcutaneously with 100 
 
m
 
g of the peptide conjugated
to KLH emulsified in CFA, and boosted sequentially with the
peptide–KLH conjugate (100 
 
m
 
g) in IFA and in saline. Specificity
was tested by ELISA with peptide-bound 96-well plates. The bi-
ological activity of the antibody was tested by its ability to neu-
tralize IL-18–induced IFN-
 
g
 
 production by cloned Th1 cells. In
brief, Th1 cells (Dorris or X4) were cultured in 96-well plates in
the presence of irradiated spleen cells and antigen, or with immo-
bilized anti–murine CD3 antibody (Sigma Chemical Co., Poole,
UK). To this was added recombinant murine IL-18 (30 ng/ml)
and a serial dilution of the rabbit anti–IL-18R antibody. Culture
supernatant was harvested at 48 h, and concentrations of IFN-
 
g
 
were determined by ELISA, using paired antibodies (PharMingen,
San Diego, CA). Total IgG was purified from the immune serum
and preimmunized serum by ammonium sulphate precipitation.
 
Flow Cytometric Analysis.
 
Cells were incubated with anti–
IL-18R or normal rabbit serum followed by biotinylated goat
anti–rabbit IgG (DAKO Corp., Carpinteria, CA) and then devel-
oped with PercP-streptavidin (Becton Dickinson, Mountain
View, CA). All reactions and washings were carried out at 4
 
8
 
C in
FACS wash buffer (PBS containing FCS [5%] and NaN
 
3
 
 [0.1%]),
and all antibodies were centrifuged (11,000 
 
g
 
 for 5 min) immedi-
ately before use. For intracellular staining, cells were suspended at
10
 
5
 
–10
 
6
 
 cells/ml and stimulated with PMA (50 ng/ml; Sigma
Chemical Co.) plus ionomycin (500 ng/ml; Sigma Chemical
Co.) for 4 h. Brefeldin A (10 ng/ml; Sigma Chemical Co.) was
added during the last 2 h. Cells were then fixed with paraformal-
dehyde (2%), and, after washing, permeabilized at room tempera-
ture with 0.5% saponin (Sigma Chemical Co.) in PBS and FCS
(5%), then stained with FITC-conjugated anti–mouse IFN-
 
g
 
(IgG2a; PharMingen) and PE-conjugated anti–mouse IL-4 (IgG2a;
PharMingen), or FITC- and PE-conjugated isotype control anti-
bodies (Becton Dickinson). After two washes with FACS wash
buffer containing 0.1% saponin, samples were analyzed on a
FACScan
 
Ò
 
 flow cytometer (Becton Dickinson).
 
Local Inflammation.
 
Groups of BALB/c mice were injected
daily with 0.5 mg i.p. of anti–IL-18R antibody or normal rabbit
IgG. They were injected in the right hind footpad with 300 
 
m
 
g of 
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lambda carrageenin (Sigma Chemical Co.) in 50 
 
m
 
l PBS 24 h af-
ter the first injection of antibody. Footpad swelling was measured
over the next 3 d with a dial calliper (Kroeplin GmbH, Munich,
Germany), and data are expressed as mean footpad thickness in-
crease (right footpad 
 
2 
 
left footpad) 
 
6
 
 SEM. Some mice were
killed 24 h after carrageenin injection, and footpad and draining
lymph nodes (DLN) were removed. Footpad was fixed in formal-
dehyde, and histology was examined for cellular infiltration after
staining with hematoxylin and eosin. DLN cells were cultured
with immobilized anti-CD3 antibody (Sigma Chemical Co.) for
48 h. Supernatants were collected for cytokine assay by ELISA
using paired antibodies (PharMingen). T cell proliferation was
analyzed by [
 
3
 
H]thymidine uptake during the last 6 h of culture.
In some experiments, mice were killed 24 h after carrageenin in-
jection, and peripheral blood was collected in heparin.
 
LPS-induced Shock.
 
Groups of BALB/c mice were injected
daily with 0.5 mg i.p. of anti–IL-18R antibody or normal rabbit
IgG. They were then challenged intraperitoneally, 24 h after the
first antibody injection, with 18 mg/kg body wt of LPS (
 
Salmo-
nella enteritidis
 
; Sigma Chemical Co.) in 0.2 ml PBS. Animals
were observed every 6 h for general health and mortality. Experi-
ments were terminated on day 4 after LPS injection as required
by the guidelines for animal experimentation, Home Office, UK.
Mice were tail-bled 2 and 24 h after LPS injection. The sera were
pooled, and concentrations of IFN-
 
g
 
, TNF-
 
a
 
, IL-4, IL-5, IL-6,
and IL-12 were determined by ELISA using paired antibodies
(PharMingen).
 
Statistical Analysis.
 
Statistical analysis was performed using
Minitab software for Macintosh. Comparison between groups
was by Mann-Whitney test or Student’s 
 
t
 
 test except for lethality
data, which were analyzed by the two-tailed log–rank test.
 
Results
 
IL-18R Message Is Consistently Expressed in Th1 but not
Th2 Cells.
 
A panel of cloned Th1 and Th2 cells were
stimulated with antigens and irradiated APCs. 5 d later,
RNA was extracted, and the expression of IL-18, IL-
12R
 
b
 
2, and ST2L was detected by the highly sensitive
RT-PCR Southern blot analysis. Data presented in Fig. 1
show that, as expected (6), Th2 but not Th1 cells expressed
ST2L. In contrast, Th1 but not Th2 cells expressed IL-
12R
 
b
 
2 and IL-18R. IL-18R expression in Th1 cells was
persistent because its message was clearly expressed for at
least 28 d when the cells were maintained in culture me-
dium containing IL-2. It should also be noted that T cell
clones derived from BALB/c (X4, X12) or CBA (Dorris,
D10) mice show a similar pattern of expression of IL-18R,
ST2L, and IL-12R
 
b
 
2 message (Fig. 1 
 
a
 
).
We then investigated whether selective expression of IL-
18R in Th1 cells also applied to newly polarized T cell
lines, and whether this was due to a selective loss of the re-
ceptor in Th2 cells during development. CD4
 
1
 
 T cells
were negatively selected from the splenic cell population of
OVA-TCR-
 
ab 
 
transgenic mice (D011.10). They were
cultured in vitro in the presence of IL-12 plus anti–IL-4
(Th1 line) or IL-4 plus anti–IL-12 and anti-IFN-
 
g
 
 (Th2
line). Cells were harvested on days 3, 5, and 7. Some cells
were driven for a second round and harvested 5 d later.
The differential expression pattern of IL-18R, IL-12R
 
b
 
2,
and ST2L was evident even as early as day 3. The Th1 line
progressively lost ST2L message and expressed strong IL-18R
and IL-12R
 
b
 
2 messages. In contrast, the Th2 line ex-
pressed strong ST2L message but little or no IL-18R or
IL-12R
 
b
 
2 mRNA (Fig. 1 
 
b
 
). This pattern became more
polarized with prolonged culture. By day 5 of the second
round of driving, IL-18R and IL-12R
 
b
 
2 message was
clearly present in Th1 lines but not detectable in Th2 lines,
whereas ST2L was present in Th2 but not in Th1 lines.
In parallel experiments, we investigated the relative sta-
bility of the expression of IL-18R, IL-12R
 
b
 
2, and ST2L in
cloned T cell lines. The clones were stimulated in vitro
with their respective antigen (peptide) and irradiated APCs,
and RNA was extracted at regular intervals. Although the
expressions of ST2L and IL-18R were stable beyond day 9,
that of IL-12R
 
b
 
2 began to decline on day 5 and was not
detectable by day 9 (Fig. 1 
 
c
 
).
 
Interactions of IL-18 and IL-12 in Th1 Cells.
 
Since IL-18
synergizes with IL-12 in the development of Th1 cells (12)
and the production of IFN-
 
g
 
 (8), we investigated the possi-
bility that these two cytokines may influence each other’s
receptor expression. Th1 clones were cultured with APCs
and antigen in the presence of IL-12, IL-18, or a combina-
tion of IL-12 and IL-18. Cells were harvested on days 3–7,
Figure 1. Selective expression
of IL-18R message in Th1 com-
pared with Th2 cells. (a) Cloned
Th1 (Dorris, X4) and Th2 cells
(D10, X12) were activated with ir-
radiated spleen cells (APCs) and
antigen. RNA were extracted 5 d
later and analyzed by RT-PCR
Southern blot with probes of IL-
18R, IL-12Rb2, ST2L, or
HPRT. (b) CD41 T cells from
D011.10 mice were polarized with
APCs and antigen in the presence
of IL-12 and anti–IL-4 antibody (Th1 line), or IL-4, anti–IL-12, and anti-IFN-g (Th2 line). The cells were harvested 3, 5, and 7 d after start of the cul-
ture or 5 d (*5) after the second round of culture. RNA was extracted and analyzed by RT-PCR Southern blot as in a above. (c) Kinetic study of the ex-
pression of messages by representative Th1 (Dorris) and Th2 (D10) clones. Cells were stimulated with APCs and antigen, and RNA was extracted for
RT-PCR Southern blot analysis on days 3, 5, and 9. For cells extracted on day 9, IL-2 was added in the culture on day 3 to maintain the viability of the
cells beyond day 7. Data are representative of four experiments. 
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and RNA was extracted. Northern blot analysis showed
that IL-12R
 
b
 
2 was sustained and increased by the presence
of IL-18, IL-12, and particularly a combination of IL-18
and IL-12, compared with cells cultured with medium
alone. In contrast, IL-18R was markedly decreased by IL-18
but increased by IL-12. A combination of IL-12 and IL-18
induced a slight decrease of IL-18R (Fig. 2). The effect of
IL-12 and IL-18 on IL-12R
 
b
 
2 was reflected in IFN-
 
g
 
 pro-
duction by the treated Th1 cells. IL-18, IL-12, and espe-
cially a combination of the two cytokines significantly in-
creased IFN-
 
g
 
 synthesis compared with cells cultured with
medium alone (data not shown). Therefore, binding of IL-18
to IL-18R appears to transmit signals for a sustained expres-
sion of IL-12R complex and the production of IFN-
 
g
 
.
Conversely, binding of IL-12 to IL-12R increased the ex-
pression of IL-18R even in the presence of IL-18. This
may account for the synergistic effect of IL-18 and IL-12 in
Th1 expansion.
 
IL-18R Is Expressed on the Surface of Th1 but not Th2
Cells. A rabbit polyclonal antibody was raised against a
peptide corresponding to the hydrophilic region of the ex-
tracellular domain of IL-18R. The antibody stained Th1
but not Th2 clones by flow cytometric analysis (Fig. 3 a).
The expression was persistent, because Th1 cells remained
IL-18R–positive after antigenic stimulation and prolonged
culture in medium containing IL-2 alone (data not shown).
To determine whether this staining pattern of IL-18R also
occurs in cells derived from naive T cells, we polarized the
splenic CD41 T cells from OVA-TCR-ab transgenic mice
(D011.10) with IL-12 and anti–IL-4 (Th1 line) or IL-4
(Th2 line) in vitro in a 6-d culture and stimulated the cells
with PMA and ionomycin for 4 h (16). They were then
stained for cell surface IL-18R and intracellular IL-4 and
IFN-g. Th1 lines stained positive for IL-18R and IFN-g, but
negative for IL-4. In contrast, the Th2 line was negative for
IL-18R and IFN-g, but positive for IL-4 (Fig. 3 b). Titra-
tion studies showed that cell surface expression of IL-18R by
Th1 cells was positively related to the concentration of IL-
12 used in the culture; 40 U/ml of IL-12 induced stronger
IL-18R expression than 20 or 10 U/ml. This is consistent
with the results reported in Fig. 2 above.
To determine whether the anti–IL-18R antibody can af-
fect Th1 functions, Th1 cells were cultured with APCs and
antigen in vitro in the presence of IL-18 (15 ng/ml) plus
IL-12 (10 ng/ml), and anti–IL-18R antibody (700 ng/ml)
or normal IgG. The antibody significantly inhibited the
production of IFN-g by Th1 cells (normal IgG versus anti–
IL-18R [mean 6 SD]: 1,140 6 130 vs. 640 6 8 ng/ml,
representative of four experiments]. However, the anti-
body had little or no effect on Th1 cell proliferation (data
not shown).
Anti–IL-18R Antibody Reduces Local Inflammation. We next
investigated the effect of anti–IL-18R antibody in vivo us-
ing an inflammatory model. BALB/c mice were injected in
the footpad with carrageenin and treated intraperitoneally
Figure 2. Effect of IL-18 and
IL-12 on the expression of IL-
18R, IL-12Rb2, and Th1 func-
tions. A representative Th1
clone (Dorris) was stimulated
with irradiated APCs and antigen
in the presence of IL-18, IL-12,
a combination of IL-18 and IL-
12, or medium alone. RNA was
extracted on day 5 and analyzed
by Northern blot. The relative
level of the message was com-
pared with reference to HPRT.
Message expressed by cells cul-
tured with medium alone was normalized as 1.0. Similar results were ob-
tained with cells cultured for 3 or 7 d.
Figure 3. Flow cytometric
analysis of cell surface expression
of IL-18R. (a) Th1 (Dorris) and
Th2 (D10) were stained with
rabbit anti–IL-18R or pre-
immune serum (1/25 dilution)
followed by biotinylated goat
anti–rabbit IgG and were devel-
oped with PerCP-streptavidin.
Similar results were obtained
with X4 (Th1) and X12 (Th2)
(not shown). (b) CD41 T cells
from OVA-TCR-ab transgenic
mice (D011.10) were driven to
Th1 or Th2 lines for 6 d with
APCs and antigen in the pres-
ence of IL-12 and anti–IL-4 an-
tibody (Th1 line) or IL-4 (Th2
line). They were stained for cell
surface IL-18R (with PerCP),
and intracellular IFN-g (with
FITC) and IL-4 (with PE). All
cells in b were activated with PMA/ionomycin for 4 h and Brefeldin A added in the last 2 h. Unfilled histograms, Staining with control preimmune serum.
Similar results were obtained with cells driven for up to five rounds of culture.1489 Xu et al.
with anti–IL-18R antibody or normal rabbit IgG. Mice
treated with anti–IL-18R antibody developed significantly
less footpad swelling within the first 48 h compared with
normal IgG-treated controls (Fig. 4 a). Histological exami-
nation revealed marked mononuclear and polymorphonu-
clear cellular infiltration in the control footpad. This was
significantly reduced in the footpad of the anti–IL-18R an-
tibody–treated mice (Fig. 4, b–d). DLN T cells from the
antibody-treated mice also produced considerably less IFN-g
and IL-6 but more IL-4 and IL-5 than those from the con-
trol mice when stimulated with anti-CD3 antibody in vitro
(Fig. 4 e). Together, these findings are consistent with the
notion that IL-18 is associated with local inflammation and
that anti–IL-18R antibody can downregulate Th1 activity
within such inflammatory responses.
Anti–IL-18R Antibody Reduces LPS-induced Shock. We
next determined whether anti–IL-18R antibody could in-
fluence LPS-induced septic shock. BALB/c mice were
injected intraperitoneally with LPS and treated with anti–
IL-18R antibody or normal rabbit IgG. While the control
IgG-treated mice developed substantial mortality, the dis-
ease was markedly reduced in the group treated with the
anti–IL-18R antibody (Fig. 5 a). The antibody-treated
mice also recovered from body weight loss more quickly
(Fig. 5 b). The beneficial effect of the anti–IL-18R anti-
body was accompanied by reduced levels of serum IFN-g,
TNF-a, and IL-6 after LPS injection (Fig. 5 c). Thus, anti–
IL-18R antibody could significantly ameliorate LPS-induced
shock and in so doing could reduce the production of
proinflammatory cytokines.
Figure 4. Effect of anti–IL-18R antibody on local inflammation. BALB/c mice were injected in the footpad with carrageenin (300 mg/50 ml/mouse).
They were also injected intraperitoneally with anti–IL-18R antibody or normal rabbit IgG (0.5 mg/mouse/d) daily for 4 d, starting 24 h before the footpad
injection. (a) Footpad swelling was measured daily. Data are mean 6 SEM; n 5 5, *P , 0.01. Footpad thickness of the antibody-treated group was indis-
tinguishable from the control at 72 h after injection. Thus, the antibody delayed the onset of local inflammation. (b) Inflammatory score of histological
examination shows extensive cellular infiltrations in the footpad of the (c) normal IgG-treated group at 24 h after carrageenin injection. This was significantly
reduced after (d) anti–IL-18R injection. Sections of the carrageenin-injected footpads were stained with hematoxylin and eosin (original magnification:
310). The number of infiltrating cells was counted and expressed as inflammatory score (0, no inflammation; 1, patchy mild inflammation; 2, patchy ex-
tensive inflammation; 3, continuous inflammation; 4, continuous inflammation with loss of architecture; n 5 5, *P , 0.01). (e) DLN were pooled (five
mice per group) 24 h after carrageenin injection and stimulated in vitro with immobilized anti-CD3 antibody. Supernatant was collected 48 h later, and
cytokine concentration was determined by ELISA. Data are mean 6 SD; n 5 3, *P , 0.05, **P , 0.01. There was no significant difference in the T cell
proliferative response between the two groups of mice (data not shown). Results are representative of three experiments.1490 IL-18R and Th1 Cells
Discussion
Data presented here demonstrate that IL-18R is selec-
tively and persistently expressed on Th1 but not Th2 cells.
Thus, IL-18R not only serves as a cell surface marker dis-
tinguishing Th1 from Th2 cells, but also provides an expla-
nation for the selective biological effect of IL-18. In addi-
tion, our data provide a mechanism by which IL-18 synergizes
with IL-12 in the expansion of Th1 cells through recipro-
cal modification of receptor expression, leading directly to
enhanced production of IFN-g. The persistent expression
of IL-18R on Th1 cells suggests that IL-18 may play a
dominant role in Th1 expansion and function. Further-
more, antibody against IL-18R affects Th1 functions in
vitro and in vivo.
It is of interest that IL-18 downregulated but did not ab-
rogate IL-18R (Fig. 2). This is consistent with a recent re-
port that IL-18–deficient mice expressed elevated IL-18R
message (13). The mechanism for this is currently un-
known, but may represent a self-limiting feedback circuit
to curtail overexpansion of Th1 cells, which have been im-
plicated in a range of immunopathologies (17, 18). This
possibility is currently being addressed. It should also be
noted that Th1 cells from both BALB/c and CBA origin
expressed substantial levels of IL-18R and IL-12Rb2 (Fig.
1) and that IL-18 could upregulate IL-12Rb2 (Fig. 2). This
suggests that the observed sustained expression of IL-12R
in CBA mice, which may account for the resistance of this
mouse strain to intracellular infection (19), may be associ-
ated with innate IL-18 expression.
IL-18 is produced by monocytic cells after pathogenic
infections (11). Since IL-18R is selectively present on a dis-
tinct subset of T cells, IL-18 likely plays an important role
beyond providing a link between innate and adaptive im-
mune response. The ability of IL-18 to support Th1 expan-
sion is determined by the selective expression of IL-18R on
Th1 cells. Therefore, it would be of considerable interest to
determine the mechanism whereby IL-18R is preferentially
expressed on Th1 but not Th2 cells during their dichoto-
mous development from a common precursor. However,
since NK cells (11, 20) and neutrophils (our unpublished
data) also express IL-18R, the rapid downregulation of
proinflammatory cytokines during LPS-induced shock by
anti–IL-18R antibody (2 h after LPS injection) may reflect
a combination of effects of the antibody on Th1 cells as
well as NK cells and neutrophils. However, the antibody
treatment did not significantly affect the percentage of
these cells in vivo (data not shown).
It is interesting that both ST2L and IL-18R, which are
preferentially and persistently expressed on Th2 and Th1
cells, respectively, belong to the type I IL-1R family. Al-
though it is now well established that cytokines play a ma-
jor role in the polarization of Th1 and Th2 cells, other fac-
tors such as MHC, antigen dose, and antigenic affinity also
appear to be important (for a review, see reference 21).
The precise mechanisms by which these factors interact to
preferentially induce Th1 and Th2 cells remain obscure.
Differential activation of the genes of the type I IL-1R
family may thus provide an answer to a central question in
immunology. There is considerable amino acid sequence
homology between the cytoplasmic domains of human IL-1R
family and the Drosophila Toll protein (22), which controls
the induction of potent antimicrobial factors in the adult
fly (23). Thus, the IL-1R family may govern an evolution-
ary ancient immune response in both insects and verte-
brates. Interestingly, all members of the IL-1R family signal
Figure 5. Effect of anti–IL-18R antibody on LPS-induced shock.
BALB/c mice were injected intraperitoneally with 18 mg/kg body wt of
LPS. They were injected daily with 0.5 mg i.p. of anti–IL-18R antibody
or normal rabbit IgG, starting 24 h before LPS injection. (a) Anti–IL-18R
antibody treatment significantly reduced mortality compared with control
(n 5 20, *P , 0.001). Results are pooled from two experiments. (b) Both
groups of mice suffered similar initial weight loss. However, the anti-
body-treated group recovered significantly more rapidly compared with
control (mean body weight of surviving mice 6 SEM; *P , 0.05, **P ,
0.01). (c) Sera were collected and pooled 2 and 24 h after LPS injection.
Cytokine concentrations in the serum were determined by ELISA. Data
are mean 6 SD of triplicate assays of the 2-h sera; *P , 0.05, **P , 0.01.
Similar results were obtained for the 24-h sera (data not shown).1491 Xu et al.
through the IL-1R–associated kinase–nuclear factor-kB
(IRAK-NF-kB) pathway (8, 24) yet lead to differential
expression and regulation of distinct T cell subsets. Unrav-
eling these detailed signaling pathways and their transcrip-
tional control represents an important challenge. It will also
be important to determine whether the homologues of these
molecules are also differentially expressed on human Th1
and Th2 cells as well as the CD81 subsets.
Knowledge of Th1 and Th2 biology was advanced con-
siderably by the demonstration that Th1 and Th2 cells can
be polarized by culturing CD41 T cells from transgenic
mice recognizing a single peptide (25, 26), marked by dif-
ferential intracellular staining of cytokines produced by the
subsets (16). However, identification of stable cell surface
markers, analogous to the CD4/CD8 molecules, capable of
recognizing live cells and contributing towards the func-
tions of Th1 and Th2 cells, would be of considerable im-
portance in advancing this field. CD30 was reported to be
expressed transiently and preferentially on cloned human
Th2 compared with Th1 cells (27). Message for IL-12Rb2
was induced on Th1 cells by IL-12 and IFN-g (28, 29).
However, the induction was again transitory. Th1 but not
Th2 cells are able to bind P-selectin and E-selectin (30),
but the ligand for the binding has not yet been clearly iden-
tified. Parallel to this finding are the recent observations
that Th1 and Th2 cells differentially express chemokine re-
ceptors (31–34). CCR3 and CCR4 are preferentially ex-
pressed on Th2 cells, whereas CCR5 and CXCR3 are se-
lectively expressed on Th1 cells. The expression of these
receptors may have important implications for the migra-
tory and activation patterns and susceptibility to HIV infec-
tion of Th1 and Th2 cells. However, these receptors are
rapidly lost upon T cell activation by IL-2, anti-CD3, and
anti-CD28 (31, 32). Data presented here demonstrate that
IL-18R is a selective and consistent cell surface marker for
Th1 cells, distinguishing them from Th2 cells.
The finding of persistent Th1 and Th2 cell surface mark-
ers directly demonstrates the validity of the Th1/Th2 clas-
sification. These markers will also facilitate investigation
into the interaction between Th1 and Th2 cells, using pure
populations of cells ex vivo. The antibodies will enable in
vivo tracking of the migratory pattern and selective interac-
tions of Th1 and Th2 cells with other cell types, including
APCs and B cells, in the induction of humoral responses.
Finally, antibodies, agonists, and antagonists for these cell
surface molecules may have important clinical applications
during infectious and autoimmune diseases in which the
balance between Th1 and Th2 cells is known to play a crit-
ical role.
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